Multidisciplinaire richtlijn Cardiovasculair ... - Diliguide

egular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J
Med 1993;329:1677-83.
Mizuno K, Nakaya N, Ohashi Y, Tajima N, Kushiro T, Teramoto T, et al. Usefulness of
pravastatin in primary prevention of cardiovascular events in women: analysis of the
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese
(MEGA study). Circulation 2008;117:494-502.
Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andrejak M. Comparison of different
therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide
versus a sequential monotherapy or a stepped-care approach. J Hypertens 2004;22:2379-
86.
Muller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in
cardiovascular mortality within Europe. Eur Heart J 2008;29:1316-26.
Mulrow CD, Chiquette E, Angel L, Cornell J, Summerbell C, Anagnostelis B, et al. Dieting to
reduce body weight for controlling hypertension in adults. Cochrane Database Syst Rev
2000;CD000484.
Myers MG, McInnis NH, Fodor GJ, Leenen FH. Comparison between an automated and
manual sphygmomanometer in a population survey. Am J Hypertens 2008;21:280-3.
Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood
pressure in the office: recognizing the problem and proposing the solution. Hypertension
2010;55:195-200.
Naranjo A, Sokka T, Descalzo MA, Calvo-Alen J, Horslev-Petersen K, Luukkainen RK, et al.
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA
study. Arthritis Res Ther 2008;10:R30.
Nationaal Instituut voor Gezondheidsbevordering en Ziektepreventie (NIGZ). Feiten over
alcohol. Woerden: NIGZ, 2004.
http://www.alcoholinfo.nl/index.cfm?act=winkel.detail&pr=715
National Institute for Health and Clinical Excellence (NICE). Hypertension: management of
hypertension in adults in primary care. NICE clinical guideline 34 (2006). http://www.nice.
org.uk/nicemedia/pdf/CG034NICEguideline.pdf
National Institute for Health and Clinical Excellence (NICE). Lipid modification:
cardiovascular risk assessment and the modification of blood lipids for the primary and
secondary prevention of cardiovascular disease. Clinical guidelines CG67 (2008). http://
www.nice.org.uk/CG67
National Institutes of Health (NIH). Clinical guidelines on the identification, evaluation, and
treatment of overweight and obesity in adults. The evidence report (1998). http://www.
nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf
Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and
other blood-pressure-lowering drugs: results of prospectively designed overviews of
randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet
2000;356:1955-64.
MULTIDISCIPLINAIRE RICHTLIJN CARDIOVASCULAIR RISICOMANAGEMENT 126